[HTML][HTML] A molecular approach in drug development for Alzheimer's disease

S Agatonovic-Kustrin, C Kettle, DW Morton - Biomedicine & …, 2018 - Elsevier
An increase in dementia numbers and global trends in population aging across the world
prompts the need for new medications to treat the complex biological dysfunctions, such as …

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998–2018)

P Mishra, A Kumar, G Panda - Bioorganic & Medicinal Chemistry, 2019 - Elsevier
Alzheimer's disease (AD) is a genetically complex, progressive and irreversible
neurodegenerative disorder of the brain which involves multiple associated etiological …

Multi-targetable chalcone analogs to treat deadly Alzheimer's disease: Current view and upcoming advice

X Zhang, KP Rakesh, SNA Bukhari, M Balakrishna… - Bioorganic …, 2018 - Elsevier
The complications of Alzheimer's disease AD were deadly dangerous cause of
neurodegenerative disorders connected with the decline of the cognitive functions and loss …

Synthesis and biological evaluation of novel tacrine derivatives and tacrine–coumarin hybrids as cholinesterase inhibitors

S Hamulakova, L Janovec, M Hrabinova… - Journal of medicinal …, 2014 - ACS Publications
A series of novel tacrine derivatives and tacrine–coumarin heterodimers were designed,
synthesized, and biologically evaluated for their potential inhibitory effect on both …

Merged tacrine-based, multitarget-directed acetylcholinesterase inhibitors 2015–present: Synthesis and biological activity

TJ Eckroat, DL Manross, SC Cowan - International journal of molecular …, 2020 - mdpi.com
Acetylcholinesterase is an important biochemical enzyme in that it controls acetylcholine-
mediated neuronal transmission in the central nervous system, contains a unique structure …

A resurrection of 7-MEOTA: a comparison with tacrine

O Soukup, D Jun, J Zdarova-Karasova… - Current Alzheimer …, 2013 - ingentaconnect.com
Alzheimer´ s disease (AD) is a progressive neurodegenerative dementia which currently
represents one of the biggest threats for the human kind. The cure is still unknown and …

Conjugates of tacrine and salicylic acid derivatives as new promising multitarget agents for Alzheimer's disease

GF Makhaeva, NV Kovaleva, EV Rudakova… - International journal of …, 2023 - mdpi.com
A series of previously synthesized conjugates of tacrine and salicylamide was extended by
varying the structure of the salicylamide fragment and using salicylic aldehyde to synthesize …

Tacrine hybrids as multi-target-directed ligands in Alzheimer's disease: Influence of chemical structures on biological activities

M Girek, P Szymański - Chemical Papers, 2019 - Springer
Alzheimer's disease is a neurological disorder, which is the most common form of dementia
affecting mostly elderly people. The number of patients is still rapidly increasing which …

Design, synthesis and biological evaluation of tacrine-1, 2, 3-triazole derivatives as potent cholinesterase inhibitors

G Wu, Y Gao, D Kang, B Huang, Z Huo, H Liu… - …, 2018 - pubs.rsc.org
We report herein the design and synthesis of a series of 11 novel tacrine-1, 2, 3-triazole
derivatives via a Cu (I)-catalyzed alkyne–azide 1, 3-dipolar cycloaddition (CuAAC) reaction …

Neurodegenerative pathways in Alzheimer's disease: a review

AK Ramachandran, S Das, A Joseph… - Current …, 2021 - ingentaconnect.com
Alzheimer's disease (AD) is a complex neurodegenerative disease that leads to insidious
deterioration of brain functions and is considered the sixth leading cause of death in the …